Archives

CARB-X awards funding to AdJane to advance its nOMV platform-derived vaccine for the prevention of gonorrhea

B Heterologous approach aims to deliver targeted, broad-spectrum immune response to Neisseria gonorrhoeae infections BOSTON, April 28, 2026 /PRNewswire/ — Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is awarding US$2.6 million…

Read MoreCARB-X awards funding to AdJane to advance its nOMV platform-derived vaccine for the prevention of gonorrhea

Ascidian to Highlight Progress of Lead Program in Stargardt and Platform Advancements Across Therapeutic Areas at ASGCT 2026 Annual Meeting

B BOSTON, April 28, 2026 /PRNewswire/ — Ascidian Therapeutics, a biotechnology company seeking to treat human diseases by rewriting RNA, today announced it will present two oral presentations and one poster…

Read MoreAscidian to Highlight Progress of Lead Program in Stargardt and Platform Advancements Across Therapeutic Areas at ASGCT 2026 Annual Meeting